Ceftriaxone Decreases MPTP-induced Behavioral Disturbances in Animal Model of Parkinson’s disease

Ceftriaxone Decreases MPTP-induced Behavioral Disturbances in Animal Model of Parkinson’s disease

Background and purpose: Progressive degeneration of dopaminergic neurons in the midbrain is the main mechanism of Parkinson’s disease (PD). Recent studies have shown ceftriaxone, a β-lactam antibiotic, to be a neuroprotective in various neurodegenerative disorders. Hence, the present study aimed to...

Full description

Bibliographic Details
Main Authors:	Mohammad Amiri, Reza Taherian, Hossein Nazari, Mahdi Taherian
Format:	Article
Language:	English
Published:	Shahid Beheshti University of Medical Sciences 2016-10-01
Series:	International Clinical Neuroscience Journal
Online Access:	http://journals.sbmu.ac.ir/Neuroscience/article/download/14365/6

Similar Items

4-Aminopyridine Decreases MPTP-Induced Behavioral Disturbances in Animal Model of Parkinson’s Disease
by: Reza Taherian, et al.
Published: (2015-10-01)

Investigation of the Effect of Cycloserine on Motor Function in a Rat Model of Parkinson’s disease
by: Reza Taherian, et al.
Published: (2017-10-01)

Brain-Derived Neurotrophic Factor is Produced in Escherichia Coli Using Transforming Plasmids
by: Reza Taherian, et al.
Published: (2016-01-01)

Behavioral characterization in MPTP/p mouse model of Parkinson’s disease
by: Mai Wada, et al.
Published: (2021-06-01)

The Relationship between Skewed X-chromosome Inactivation and Neurological Disorders Development
by: Mahdi Taherian, et al.
Published: (2016-04-01)

Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
by: Francesco Napolitano, et al.
Published: (2017-01-01)

SOCIAL BEHAVIORAL CHANGES IN MPTP-TREATED MONKEY MODEL OF PARKINSON’S DISEASE.
by: Elodie eDURAND, et al.
Published: (2015-02-01)

<i>Srpk3</i> Decrease Associated with Alpha-Synuclein Increase in Muscles of MPTP-Induced Parkinson’s Disease Mice
by: Min Hyung Seo, et al.
Published: (2021-08-01)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Non-Motor Symptoms of Parkinson’s Disease and HealthRelated Quality of Life: A Mini-Review
by: Ali Zafari, et al.
Published: (2017-01-01)

Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson’s Disease
by: Sangeun Han, et al.
Published: (2022-05-01)

Antiparkinsonian effect of dicholine succinate on the model of MPTP-induced parkinsonism
by: A. K. Sariev, et al.
Published: (2017-02-01)

Profit maximization for an electricity retailer using a novel customers’ behavior leaning in a smart grid environment
by: Hossein Taherian, et al.
Published: (2022-11-01)

Landau Kleffner Syndrome and Misdiagnosis of Autism Spectrum Disorder: A Mini-Review
by: Ali Zafari, et al.
Published: (2018-01-01)

Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model
by: Noor Azzizah Omar, et al.
Published: (2023-11-01)

Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model
by: Dong Geun Hong, et al.
Published: (2022-09-01)

Neuroprotective Effect of Ghrelin on Substantia Nigra in Parkinson Disease Model Induced -MPTP
by: Neda Nikoklam Nazif
Published: (2019-10-01)

Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson’s Disease
by: Min Hyung Seo, et al.
Published: (2023-11-01)

The Effect of Aqueous Extract of Rosemary )Rosmarinus officinalis) on Parkinson\'s Disease Induced by MPTP in Male Mice
by: Mohammad Amani, et al.
Published: (2023-03-01)

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
by: Yingjuan Liu, et al.
Published: (2020-08-01)

Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys
by: Mathilde Millot, et al.
Published: (2020-02-01)

MPTP-induced mouse model of Parkinson’s disease: a promising direction for therapeutic strategies
by: Mustapha, Musa, et al.
Published: (2021)

Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
by: Seulah Lee, et al.
Published: (2021-02-01)

Effect of Eleutheroside E on an MPTP-Induced Parkinson’s Disease Cell Model and Its Mechanism
by: Yi Yao, et al.
Published: (2023-04-01)

Rapamycin reverses ferroptosis by increasing autophagy in MPTP/MPP+-induced models of Parkinson’s disease
by: Tongyu Liu, et al.
Published: (2023-01-01)

Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease
by: Yaozhen Wang, et al.
Published: (2018-09-01)

“Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease”
by: Alfredo Rodríguez-Cruz, et al.
Published: (2020-06-01)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
by: Noor Azzizah Omar, et al.
Published: (2023-08-01)

The Dynamism of the Political Economy of Space, Physical Imbalance and Visual Disturbance (Case Study: Shahrdari Street from Tajrish Square to Quds Square)
by: Nazli Taherian, et al.
Published: (2023-06-01)

The Effects of Serping1 siRNA in α-Synuclein Regulation in MPTP-Induced Parkinson’s Disease
by: Min Hyung Seo, et al.
Published: (2023-07-01)

Defining Specific Cell States of MPTP-Induced Parkinson’s Disease by Single-Nucleus RNA Sequencing
by: Yunxia Guo, et al.
Published: (2022-09-01)

Expression Analysis of Genes Involved in Transport Processes in Mice with MPTP-Induced Model of Parkinson’s Disease
by: Margarita M. Rudenok, et al.
Published: (2022-05-01)

VANILLIN MITIGATES BEHAVIOURAL ALTERATIONS AND OXIDATIVE STRESS IN AN MPTP-INDUCED MOUSE MODEL OF PARKINSON’S DISEASE
by: Linchi Rani, et al.
Published: (2023-10-01)

Coronarin D attenuates MPTP-induced Parkinson’s disease in mice by inhibition of oxidative stress and apoptosis
by: Qiong Wu, et al.
Published: (2022-12-01)

Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson’s disease
by: Jiangbo Song, et al.
Published: (2022-10-01)

Expression analysis of genes involved in mitochondrial biogenesis in mice with MPTP-induced model of Parkinson's disease
by: M.M. Rudenok, et al.
Published: (2020-06-01)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
by: Hu S, et al.
Published: (2020-03-01)

Ceftriaxone-induced Agranulocytosis
by: Lénio Couto, et al.
Published: (2021-01-01)

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
by: Maria Fazzari, et al.
Published: (2023-04-01)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
by: Katie K. N. Tran, et al.
Published: (2022-05-01)